Business Standard

COVAX gains access to 2 billion doses of vaccines for 190 member economies

First deliveries are expected to begin in the first quarter of 2021 depending upon regulatory approvals and readiness of countries for delivery

Vaccine
Premium

COVAX has also secured the first right of refusal of successful vaccine production as part of research and development arrangements.

Ruchika Chitravanshi New Delhi
The global COVAX alliance which aims to ensure equitable access to Covid-19 vaccines for low income countries said on Friday that it had arrangements in place to access nearly two billion doses of the coronavirus vaccine candidates, on behalf of 190 participating economies.

COVAX, also known as the Covid-19 Vaccines Global Access Facility, is a global collaboration for speeding up the development, manufacture and equitable distribution of coronavirus vaccines. It is led by Gavi - global vaccine alliance, the Coalition for Epidemic Preparedness Innovations and the WHO. 

COVAX alliance, of which India is a part, has signed an advance purchase agreement with

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in